NCT06439225 Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes Status RECRUITING Phase PHASE3
NCT06431633 Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free. Status RECRUITING Phase PHASE3
NCT06422143 Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023] Status RECRUITING Phase PHASE3
NCT06419673 Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06417814 A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT06416410 JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation Status RECRUITING Phase PHASE3
NCT06413992 Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer Status RECRUITING Phase PHASE2
NCT06412471 A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC Patients Status RECRUITING Phase PHASE2
NCT06407310 Neoadjuvant Pembrolizumab, Carboplatin and Paclitaxel in Triple-negative Breast Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06404736 QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk TNBC Breast Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06403878 Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer Status RECRUITING Phase PHASE2
NCT06401330 A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT) Status RECRUITING Phase PHASE3
NCT06400472 A Study of LY4170156 in Participants With Selected Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06391008 Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06385080 A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06368817 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma Status RECRUITING Phase PHASE2
NCT06366945 Tirelizumab in Combination With Carboplatin and Polymeric Micellar Paclitaxel for Neoadjuvant Therapy in cN+ HNSCC Status NOT_YET_RECRUITING Phase PHASE2
NCT06363708 Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer Status NOT_YET_RECRUITING Phase NA
NCT06362252 A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) Status RECRUITING Phase PHASE1/PHASE2